GMP IPO Watch
Equity Scheme - Sectoral/ Thematic
Tata Ethical Fund
Direct Plan · Payout of IDCW Option · Tata Mutual Fund
Risk: Very High Risk
52W Low ₹207.97 8 Oct 2026
52W High ₹249.65 7 Jan 2026
₹219.8468
NAV as of 3 Nov 2026
+1.04% day change
Other Plans of This Fund
ISININF277K01NE9
Scheme Code119171
StructureOpen Ended Schemes
Fund HouseTata Asset Management Private Limited
AUM (avg. July - September 2026)₹30.84 Cr
Expense Ratio (as of 3 Nov 2026)0.83%
Min. Investment₹5,000
Inception Date1 Jan 2013
BenchmarkNifty 500 Shariah TRI
Portfolio Turnover15.23%
NFO Period09-Apr-1996 – 23-May-1996
Returns
1Y
-9.17%
3Y
+4.89%
5Y
+5.72%
7Y
+12.51%
10Y
+10.36%
Since Inception
+12.26%
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +2.40% | +2.62% | 183 of 255 |
| 1M | +3.90% | +0.77% | 28 of 255 |
| 3M | -5.11% | -4.63% | 140 of 252 |
| 6M | -0.87% | +2.44% | 180 of 251 |
| YTD | -10.63% | +0.02% | 228 of 255 |
| 1Y | -9.17% | -0.51% | 195 of 232 |
| 2Y | -6.37% | +1.57% | 173 of 187 |
| 3Y | +4.89% | +11.99% | 127 of 142 |
| 5Y | +5.72% | +9.56% | 83 of 102 |
| 7Y | +12.51% | +14.11% | 57 of 84 |
| 10Y | +10.36% | +11.42% | 45 of 68 |
| INCEPTION | +12.26% | — | — |
Ranked among: Equity Scheme - Sectoral/ Thematic.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +3.35% | +27.95% | -25.36% | 67% | 27% |
| 6M | +6.88% | +43.31% | -23.73% | 67% | 27% |
| 1Y | +14.96% | +85.77% | -22.03% | 73% | 31% |
| 2Y | +14.03% | +54.29% | -13.14% | 86% | 38% |
| 3Y | +13.46% | +32.58% | -5.47% | 98% | 43% |
| 5Y | +13.32% | +25.92% | -2.54% | 99% | 44% |
| 7Y | +13.03% | +16.87% | +7.39% | 100% | 45% |
| 10Y | +13.10% | +16.14% | +9.34% | 100% | 45% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity94.64%
- Debt0.00%
- Cash5.36%
- Other0.00%
Market Cap Split
- Large Cap52.70%
- Mid Cap27.17%
- Small Cap13.58%
- Others6.55%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 25.74 | 28.09 |
| P/B | 3.81 | 4.63 |
| Price / Sales | 2.36 | 3.31 |
| Price / Cash Flow | 19.13 | 21.08 |
| Dividend Yield (%) | 1.82 | 1.16 |
Holdings54
Top 5 Stocks22.32%
Top 10 Stocks36.00%
Top 3 Sectors49.66%
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Infosys | IT - Software | 6.79% | -0.46% |
| CASH / NET CURRENT ASSET | Net Current Assets | 5.36% | — |
| Tata Consultancy Services | IT - Software | 5.26% | -0.50% |
| Tech Mahindra | IT - Software | 3.73% | +0.00% |
| Dr Reddys Laboratories | Pharmaceuticals & Biotechnology | 3.37% | +0.41% |
| HCL Technologies | IT - Software | 3.17% | +0.00% |
| Hindustan Unilever | Diversified FMCG | 2.95% | +0.05% |
| Bharat Heavy Electricals | Electrical Equipment | 2.93% | +0.01% |
| Jindal Steel | Ferrous Metals | 2.82% | +0.04% |
| SRF | Chemicals & Petrochemicals | 2.49% | +0.07% |
| UltraTech Cement | Cement & Cement Products | 2.49% | +0.05% |
| Cipla | Pharmaceuticals & Biotechnology | 2.36% | +0.04% |
| Sun Pharmaceutical | Pharmaceuticals & Biotechnology | 2.34% | -0.06% |
| Alkem Laboratories | Pharmaceuticals & Biotechnology | 2.14% | +0.07% |
| Fortis Healthcare | Equity | 2.13% | -0.22% |
View all 55 holdings
| Exide Industries | Auto Components | 2.12% | +0.00% |
| LTM | IT - Software | 2.12% | -0.11% |
| Mphasis | IT - Software | 2.08% | -0.12% |
| Hindalco Industries | Non - Ferrous Metals | 2.08% | -0.02% |
| Britannia Industries | Food Products | 2.00% | -0.04% |
| Nestle | Food Products | 1.92% | -0.13% |
| Gujarat Fluorochemicals | Chemicals & Petrochemicals | 1.69% | +0.00% |
| Crompton Greaves | Consumer Durables | 1.66% | -0.09% |
| Cummins | Industrial Products | 1.65% | -0.01% |
| Swiggy | Retailing | 1.65% | -0.09% |
| Persistent Systems | IT - Software | 1.63% | +0.01% |
| IPCA Laboratories | Pharmaceuticals & Biotechnology | 1.54% | +0.06% |
| Samvardhana Motherson International | Auto Components | 1.47% | +0.03% |
| Carborundum Universal | Industrial Products | 1.34% | +0.23% |
| Indus Towers | Telecom - Services | 1.34% | +0.03% |
| Endurance Technologies | Auto Components | 1.32% | -0.01% |
| Amara Raja Energy & Mobility | Auto Components | 1.25% | — |
| Motherson Sumi Wiring | Auto Components | 1.23% | +0.32% |
| Sona BLW Precision Forgings | Auto Components | 1.22% | — |
| Syngene International | Equity | 1.19% | -0.04% |
| Tata Gold ETF | CAPITAL MARKETS | 1.19% | +0.80% |
| Colgate Palmolive | Personal Products | 1.15% | -0.01% |
| Asian Paints | Consumer Durables | 1.14% | -0.04% |
| Tata Chemicals | Chemicals & Petrochemicals | 1.10% | +0.01% |
| Bharat Petroleum | Petroleum Products | 1.09% | -1.09% |
| Dixon Technologies | Consumer Durables | 1.09% | -0.06% |
| Sundram Fasteners | Auto Components | 0.98% | +0.01% |
| UNO Minda | Auto Components | 0.94% | -0.03% |
| Gujarat State Fertilizers & Chemicals | Fertilizers & Agrochemicals | 0.93% | +0.02% |
| Godrej Consumer Products | Personal Products | 0.90% | +0.00% |
| Birlasoft | IT - Software | 0.90% | -0.01% |
| MRF | Auto Components | 0.85% | +0.00% |
| Avenue Supermarts DMart | Retailing | 0.77% | +0.03% |
| Hyundai Motor India | Automobiles | 0.70% | -0.01% |
| Cyient | IT - Services | 0.69% | +0.00% |
| Tata Consumer Products | Agricultural Food & other Products | 0.68% | -0.02% |
| Schaeffler India | Auto Components | 0.66% | +0.03% |
| 3M India | Diversified | 0.62% | +0.02% |
| Supreme Industries | Industrial Products | 0.60% | +0.02% |
| Sanofi | Pharmaceuticals & Biotechnology | 0.19% | +0.01% |
Sector Allocation · Sep 2026
View all 23 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 13.72 | 16.27 | Low Volatility |
| 3Y | 13.03 | 16.10 | Low Volatility |
| 5Y | 13.19 | 15.66 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -1.10 | -0.33 | Below Average |
| 3Y | -0.01 | -0.46 | Above Average |
| 5Y | 0.07 | 0.28 | Below Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.85% (published 2026-10-27).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.84 | 0.05 | Below Average |
| 3Y | 0.60 | 1.11 | Below Average |
| 5Y | 0.68 | 0.94 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
|
+59.16% | +48.17% | — | +23.57% |
|
HDFC Pharma and Healthcare Fund
Direct Plan · IDCW Option
|
+23.60% | +30.61% | — | +29.76% |
|
Kotak Healthcare Fund
Regular Plan · IDCW Option
|
+21.84% | — | — | +19.69% |
|
ICICI Prudential US Bluechip Equity Fund
Regular Plan · IDCW
|
+20.06% | +19.12% | +12.26% | +15.80% |
|
SBI Automotive Opportunities Fund
Direct Plan · IDCW
|
+19.95% | — | — | +10.69% |
|
Nippon India Japan Equity Fund
Regular Plan · Bonus Option
|
+19.94% | +20.37% | +8.45% | +8.55% |
|
Mirae Asset Healthcare Fund
Direct Plan · Growth
|
+19.10% | +23.89% | +16.63% | +21.84% |
|
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
|
+18.27% | — | — | +11.09% |
|
WhiteOak Capital Pharma and Healthcare Fund
Regular Plan · Growth Option
|
+17.09% | — | — | +20.29% |
|
quant Healthcare Fund
Direct Plan · Growth Option
|
+17.00% | +21.16% | — | +21.00% |
More From Tata Asset Management Private Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Tata Nifty Capital Markets Index Fund
Direct Plan · IDCW Payout Option
|
+18.83% | — | — | +22.12% |
| Tata Silver Exchange Traded Fund | +18.13% | — | — | +36.90% |
|
Tata Silver ETF Fund of Fund
Direct Plan · IDCW Reinvestment Option
|
+16.38% | — | — | +34.86% |
|
Tata Nifty MidSmall Healthcare Index Fund
Direct Plan · IDCW Reinvestment Option
|
+16.11% | — | — | +17.97% |
| Tata Gold Exchange Traded Fund | +12.63% | — | — | +31.54% |
|
Tata Gold ETF Fund of Fund
Direct Plan · IDCW Reinvestment Option
|
+12.36% | — | — | +30.26% |
|
Tata Arbitrage Fund
Direct Plan · Monthly Payout of Income Distribution cum capital withdrawal option
|
+6.93% | +7.46% | +6.97% | +5.90% |
|
Tata Ultra Short Term Fund
Direct Plan · Monthly Reinvestment of Income Distribution cum capital withdrawal option
|
+6.91% | +7.27% | +6.73% | +6.48% |
|
Tata Liquid Fund
Direct Plan · Growth Option
|
+6.47% | +6.92% | +6.43% | +6.86% |
|
Tata Money Market Fund
Direct Plan · Growth Option
|
+6.47% | +7.44% | +6.90% | +6.76% |
About This Scheme
Investment Objective
The investment objective of the Scheme is to provide medium to long- term capital gains by investing in Shariah compliant equity and equity related instruments of well-researched value and growth - oriented companies.
Stated Asset Allocation
Equity & Equity Related instruments of Shariah compliant companies 80-100, Other Shariah compliant instruments including Cash 0-20. Units of Equity Mutual funds will be considered under allocation for Equity and Equity related instruments
Exit Load
0.50% of NAV if redeemed/switched out on or before 90 days from the date of allotment
Fund Managers
Abhinav Sharma
Primary
Official Documents
Scheme Information Document (PDF)
Scheme Summary (PDF)
Scheme Summary (XLS)
Tata Asset Management Private Limited website
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.